12/16/14 - 11:38 AM EST
Opko gains $295 million up front for global license to develop, market long-acting HGH.
10/22/14 - 11:36 AM EDT
Amgen plans to expound on plans for the company at its Oct. 28 investor meeting.
10/06/14 - 02:28 PM EDT
Cash, stock $12.2 billion deal would solidify BD position in infection control, respiratory care.
09/29/14 - 11:13 AM EDT
Perrigo gains women's health assets, Amag Pharmaceuticals buys Makena line in the transaction.
09/17/14 - 11:50 AM EDT
The unsolicited bid comes a week after the Pennsylvania target announced a plant to cut 30% of its workforce.
09/15/14 - 11:08 AM EDT
Teaneck, N.J.-based information technology solutions company Cognizant Technology Solutions is adding the operations of TriZetto to create a fully integrated healthcare technology and operations leader.
08/27/14 - 09:19 AM EDT
As more companies seek tax savings through inversions, strategic reasons still remain for drug company deals.
07/17/14 - 10:17 AM EDT
Fresh from AstraZeneca plc's rebuff of its $117 billion offer, Pfizer is setting its sights on a much smaller deal in the U.S. by acquiring InnoPharma.
07/15/14 - 09:44 AM EDT
Target produces radiofrequency ablation systems, boosting the buyer's pain management business.
07/09/14 - 01:05 PM EDT
Building on the M&A trend for tax inversion deals, Salix Pharmaceuticals and Italy's Cosmo Pharmaceuticals plan to merge.